,
your personalized virtual assistant to find clinical trials. Go head, 
Christopher H van Dyck, MD
Alzheimer's Disease Research Unit, Yale ...New Haven, Connecticut - 06510 Yale University School of MedicineNew Haven, Connecticut - 06519 (203-974-7043) |
- CLINICAL TRIALS 3
- CONDITIONS2
- INTERVENTIONS4
- SINCE2008
Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects
June 2009 - August 2011
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
April 2010 - December 2012
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer s Disease
December 2008 - July 2011
Alzheimer Disease
Cognition Disorders
Placebo
Guanfacine
Immune Globulin Intravenous (Human), 10% (Igiv, 10%)
Placebo Solution
